January 28, 2022
3 min watch
Save
VIDEO: Screen psoriasis patients for cardiovascular risk factors
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
WAILEA, Hawaii — In this video perspective from Maui Derm for Dermatologists, Joel M. Gelfand, MD, MSCE, discusses the latest research regarding comorbidities associated with psoriatic disease.
According to Gelfand, cardiovascular risk factors are one of the comorbidities for which psoriasis patients are often not screened.
Published by:
Sources/Disclosures
Collapse
Source:
Joel M. Gelfand, MD, MSCE
Disclosures:
Gelfand reports consulting for Bristol Myers Squibb, Boehringer Ingelheim, GlaxoSmithKline, Lilly (DMC), Janssen Biologics, Novartis Corp, UCB (DSMB); receiving research grants (to the Trustees of the University of Pennsylvania) from AbbVie, Boehringer Ingelheim, Janssen, Novartis Corp, Amgen, and Pfizer Inc.; serving as deputy editor for the Journal of Investigative Dermatology; receiving honoraria from the Society for Investigative Dermatology; and serving on the board of directors for the International Psoriasis Council.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.